Morepen Laboratories Limited
NSE:MOREPENLAB.NS
83.34 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Morepen Laboratories Limited |
Symbool | MOREPENLAB.NS |
Munteenheid | INR |
Prijs | 83.34 |
Beurswaarde | 45,666,486,360 |
Dividendpercentage | 0% |
52-weken bereik | 35.6 - 100.9 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Sushil Suri B.Sc., F.C.A., FCA |
Website | https://www.morepen.com |
An error occurred while fetching data.
Over Morepen Laboratories Limited
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)